Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal Disease Article Swipe
Kamran A. Ahmed
,
Priya Kumthekar
,
Yolanda Piña
,
Youngchul Kim
,
Michael A. Vogelbaum
,
Hyo S. Han
,
Peter Forsyth
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1001/jamaoncol.2024.1299
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1001/jamaoncol.2024.1299
This nonrandomized controlled trial examines the safety of radiation therapy (RT) followed by intrathecal trastuzumab and pertuzumab for patients with ERBB2-positive breast leptomeningeal disease (LMD).
Related Topics
Concepts
Medicine
Pertuzumab
Trastuzumab
Oncology
Internal medicine
Breast cancer
Disease
Clinical trial
Intrathecal
Surgery
Cancer
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1001/jamaoncol.2024.1299
- OA Status
- green
- Cited By
- 7
- References
- 6
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4398254632
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4398254632Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1001/jamaoncol.2024.1299Digital Object Identifier
- Title
-
Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal DiseaseWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-05-23Full publication date if available
- Authors
-
Kamran A. Ahmed, Priya Kumthekar, Yolanda Piña, Youngchul Kim, Michael A. Vogelbaum, Hyo S. Han, Peter ForsythList of authors in order
- Landing page
-
https://doi.org/10.1001/jamaoncol.2024.1299Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/11117144Direct OA link when available
- Concepts
-
Medicine, Pertuzumab, Trastuzumab, Oncology, Internal medicine, Breast cancer, Disease, Clinical trial, Intrathecal, Surgery, CancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
7Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 5, 2024: 2Per-year citation counts (last 5 years)
- References (count)
-
6Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4398254632 |
|---|---|
| doi | https://doi.org/10.1001/jamaoncol.2024.1299 |
| ids.doi | https://doi.org/10.1001/jamaoncol.2024.1299 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38780965 |
| ids.openalex | https://openalex.org/W4398254632 |
| fwci | 6.03836199 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000008 |
| mesh[1].descriptor_ui | D000068878 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | administration & dosage |
| mesh[1].descriptor_name | Trastuzumab |
| mesh[2].qualifier_ui | Q000627 |
| mesh[2].descriptor_ui | D000068878 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | therapeutic use |
| mesh[2].descriptor_name | Trastuzumab |
| mesh[3].qualifier_ui | Q000188 |
| mesh[3].descriptor_ui | D001943 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | drug therapy |
| mesh[3].descriptor_name | Breast Neoplasms |
| mesh[4].qualifier_ui | Q000532 |
| mesh[4].descriptor_ui | D001943 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | radiotherapy |
| mesh[4].descriptor_name | Breast Neoplasms |
| mesh[5].qualifier_ui | Q000473 |
| mesh[5].descriptor_ui | D001943 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | pathology |
| mesh[5].descriptor_name | Breast Neoplasms |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D005260 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Female |
| mesh[7].qualifier_ui | Q000378 |
| mesh[7].descriptor_ui | D018719 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | metabolism |
| mesh[7].descriptor_name | Receptor, ErbB-2 |
| mesh[8].qualifier_ui | Q000627 |
| mesh[8].descriptor_ui | D061067 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | therapeutic use |
| mesh[8].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[9].qualifier_ui | Q000008 |
| mesh[9].descriptor_ui | D061067 |
| mesh[9].is_major_topic | True |
| mesh[9].qualifier_name | administration & dosage |
| mesh[9].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D007278 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Injections, Spinal |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D008875 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Middle Aged |
| mesh[12].qualifier_ui | Q000556 |
| mesh[12].descriptor_ui | D008577 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | secondary |
| mesh[12].descriptor_name | Meningeal Neoplasms |
| mesh[13].qualifier_ui | Q000532 |
| mesh[13].descriptor_ui | D008577 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | radiotherapy |
| mesh[13].descriptor_name | Meningeal Neoplasms |
| mesh[14].qualifier_ui | Q000188 |
| mesh[14].descriptor_ui | D008577 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | drug therapy |
| mesh[14].descriptor_name | Meningeal Neoplasms |
| mesh[15].qualifier_ui | Q000627 |
| mesh[15].descriptor_ui | D000971 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | therapeutic use |
| mesh[15].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D000328 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Adult |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000368 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Aged |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | Q000008 |
| mesh[19].descriptor_ui | D000068878 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | administration & dosage |
| mesh[19].descriptor_name | Trastuzumab |
| mesh[20].qualifier_ui | Q000627 |
| mesh[20].descriptor_ui | D000068878 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | therapeutic use |
| mesh[20].descriptor_name | Trastuzumab |
| mesh[21].qualifier_ui | Q000188 |
| mesh[21].descriptor_ui | D001943 |
| mesh[21].is_major_topic | True |
| mesh[21].qualifier_name | drug therapy |
| mesh[21].descriptor_name | Breast Neoplasms |
| mesh[22].qualifier_ui | Q000532 |
| mesh[22].descriptor_ui | D001943 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | radiotherapy |
| mesh[22].descriptor_name | Breast Neoplasms |
| mesh[23].qualifier_ui | Q000473 |
| mesh[23].descriptor_ui | D001943 |
| mesh[23].is_major_topic | True |
| mesh[23].qualifier_name | pathology |
| mesh[23].descriptor_name | Breast Neoplasms |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D005260 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Female |
| mesh[25].qualifier_ui | Q000378 |
| mesh[25].descriptor_ui | D018719 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | metabolism |
| mesh[25].descriptor_name | Receptor, ErbB-2 |
| mesh[26].qualifier_ui | Q000627 |
| mesh[26].descriptor_ui | D061067 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | therapeutic use |
| mesh[26].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[27].qualifier_ui | Q000008 |
| mesh[27].descriptor_ui | D061067 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | administration & dosage |
| mesh[27].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D007278 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Injections, Spinal |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D008875 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Middle Aged |
| mesh[30].qualifier_ui | Q000556 |
| mesh[30].descriptor_ui | D008577 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | secondary |
| mesh[30].descriptor_name | Meningeal Neoplasms |
| mesh[31].qualifier_ui | Q000532 |
| mesh[31].descriptor_ui | D008577 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | radiotherapy |
| mesh[31].descriptor_name | Meningeal Neoplasms |
| mesh[32].qualifier_ui | Q000188 |
| mesh[32].descriptor_ui | D008577 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | drug therapy |
| mesh[32].descriptor_name | Meningeal Neoplasms |
| mesh[33].qualifier_ui | Q000627 |
| mesh[33].descriptor_ui | D000971 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | therapeutic use |
| mesh[33].descriptor_name | Antineoplastic Combined Chemotherapy Protocols |
| mesh[34].qualifier_ui | |
| mesh[34].descriptor_ui | D000328 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | |
| mesh[34].descriptor_name | Adult |
| mesh[35].qualifier_ui | |
| mesh[35].descriptor_ui | D000368 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | |
| mesh[35].descriptor_name | Aged |
| mesh[36].qualifier_ui | |
| mesh[36].descriptor_ui | D006801 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | |
| mesh[36].descriptor_name | Humans |
| mesh[37].qualifier_ui | Q000008 |
| mesh[37].descriptor_ui | D000068878 |
| mesh[37].is_major_topic | True |
| mesh[37].qualifier_name | administration & dosage |
| mesh[37].descriptor_name | Trastuzumab |
| mesh[38].qualifier_ui | Q000627 |
| mesh[38].descriptor_ui | D000068878 |
| mesh[38].is_major_topic | True |
| mesh[38].qualifier_name | therapeutic use |
| mesh[38].descriptor_name | Trastuzumab |
| mesh[39].qualifier_ui | Q000188 |
| mesh[39].descriptor_ui | D001943 |
| mesh[39].is_major_topic | True |
| mesh[39].qualifier_name | drug therapy |
| mesh[39].descriptor_name | Breast Neoplasms |
| mesh[40].qualifier_ui | Q000532 |
| mesh[40].descriptor_ui | D001943 |
| mesh[40].is_major_topic | True |
| mesh[40].qualifier_name | radiotherapy |
| mesh[40].descriptor_name | Breast Neoplasms |
| mesh[41].qualifier_ui | Q000473 |
| mesh[41].descriptor_ui | D001943 |
| mesh[41].is_major_topic | True |
| mesh[41].qualifier_name | pathology |
| mesh[41].descriptor_name | Breast Neoplasms |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D005260 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Female |
| mesh[43].qualifier_ui | Q000378 |
| mesh[43].descriptor_ui | D018719 |
| mesh[43].is_major_topic | True |
| mesh[43].qualifier_name | metabolism |
| mesh[43].descriptor_name | Receptor, ErbB-2 |
| mesh[44].qualifier_ui | Q000627 |
| mesh[44].descriptor_ui | D061067 |
| mesh[44].is_major_topic | True |
| mesh[44].qualifier_name | therapeutic use |
| mesh[44].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[45].qualifier_ui | Q000008 |
| mesh[45].descriptor_ui | D061067 |
| mesh[45].is_major_topic | True |
| mesh[45].qualifier_name | administration & dosage |
| mesh[45].descriptor_name | Antibodies, Monoclonal, Humanized |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D007278 |
| mesh[46].is_major_topic | True |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Injections, Spinal |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D008875 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Middle Aged |
| mesh[48].qualifier_ui | Q000556 |
| mesh[48].descriptor_ui | D008577 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | secondary |
| mesh[48].descriptor_name | Meningeal Neoplasms |
| mesh[49].qualifier_ui | Q000532 |
| mesh[49].descriptor_ui | D008577 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | radiotherapy |
| mesh[49].descriptor_name | Meningeal Neoplasms |
| type | article |
| title | Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal Disease |
| biblio.issue | 7 |
| biblio.volume | 10 |
| biblio.last_page | 984 |
| biblio.first_page | 984 |
| topics[0].id | https://openalex.org/T11600 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Brain Metastases and Treatment |
| topics[1].id | https://openalex.org/T12212 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9973000288009644 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | CNS Lymphoma Diagnosis and Treatment |
| topics[2].id | https://openalex.org/T10129 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9955999851226807 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2716 |
| topics[2].subfield.display_name | Genetics |
| topics[2].display_name | Glioma Diagnosis and Treatment |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9826472997665405 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2781164504 |
| concepts[1].level | 5 |
| concepts[1].score | 0.9641977548599243 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1998021 |
| concepts[1].display_name | Pertuzumab |
| concepts[2].id | https://openalex.org/C2779786085 |
| concepts[2].level | 4 |
| concepts[2].score | 0.8671704530715942 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q412616 |
| concepts[2].display_name | Trastuzumab |
| concepts[3].id | https://openalex.org/C143998085 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5682473182678223 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[3].display_name | Oncology |
| concepts[4].id | https://openalex.org/C126322002 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5138469338417053 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[4].display_name | Internal medicine |
| concepts[5].id | https://openalex.org/C530470458 |
| concepts[5].level | 3 |
| concepts[5].score | 0.4716452956199646 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q128581 |
| concepts[5].display_name | Breast cancer |
| concepts[6].id | https://openalex.org/C2779134260 |
| concepts[6].level | 2 |
| concepts[6].score | 0.47070690989494324 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[6].display_name | Disease |
| concepts[7].id | https://openalex.org/C535046627 |
| concepts[7].level | 2 |
| concepts[7].score | 0.4332830309867859 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q30612 |
| concepts[7].display_name | Clinical trial |
| concepts[8].id | https://openalex.org/C157820659 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4167848229408264 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1320251 |
| concepts[8].display_name | Intrathecal |
| concepts[9].id | https://openalex.org/C141071460 |
| concepts[9].level | 1 |
| concepts[9].score | 0.28397586941719055 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q40821 |
| concepts[9].display_name | Surgery |
| concepts[10].id | https://openalex.org/C121608353 |
| concepts[10].level | 2 |
| concepts[10].score | 0.1488800346851349 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[10].display_name | Cancer |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9826472997665405 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/pertuzumab |
| keywords[1].score | 0.9641977548599243 |
| keywords[1].display_name | Pertuzumab |
| keywords[2].id | https://openalex.org/keywords/trastuzumab |
| keywords[2].score | 0.8671704530715942 |
| keywords[2].display_name | Trastuzumab |
| keywords[3].id | https://openalex.org/keywords/oncology |
| keywords[3].score | 0.5682473182678223 |
| keywords[3].display_name | Oncology |
| keywords[4].id | https://openalex.org/keywords/internal-medicine |
| keywords[4].score | 0.5138469338417053 |
| keywords[4].display_name | Internal medicine |
| keywords[5].id | https://openalex.org/keywords/breast-cancer |
| keywords[5].score | 0.4716452956199646 |
| keywords[5].display_name | Breast cancer |
| keywords[6].id | https://openalex.org/keywords/disease |
| keywords[6].score | 0.47070690989494324 |
| keywords[6].display_name | Disease |
| keywords[7].id | https://openalex.org/keywords/clinical-trial |
| keywords[7].score | 0.4332830309867859 |
| keywords[7].display_name | Clinical trial |
| keywords[8].id | https://openalex.org/keywords/intrathecal |
| keywords[8].score | 0.4167848229408264 |
| keywords[8].display_name | Intrathecal |
| keywords[9].id | https://openalex.org/keywords/surgery |
| keywords[9].score | 0.28397586941719055 |
| keywords[9].display_name | Surgery |
| keywords[10].id | https://openalex.org/keywords/cancer |
| keywords[10].score | 0.1488800346851349 |
| keywords[10].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.1001/jamaoncol.2024.1299 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S2756165422 |
| locations[0].source.issn | 2374-2437, 2374-2445 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2374-2437 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | JAMA Oncology |
| locations[0].source.host_organization | https://openalex.org/P4310320259 |
| locations[0].source.host_organization_name | American Medical Association |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320259 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | JAMA Oncology |
| locations[0].landing_page_url | https://doi.org/10.1001/jamaoncol.2024.1299 |
| locations[1].id | pmid:38780965 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | JAMA oncology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38780965 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:11117144 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | JAMA Oncol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11117144 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5062612957 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-3331-1529 |
| authorships[0].author.display_name | Kamran A. Ahmed |
| authorships[0].countries | US |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I3019308854 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida |
| authorships[0].institutions[0].id | https://openalex.org/I3019308854 |
| authorships[0].institutions[0].ror | https://ror.org/01xf75524 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I3019308854 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Moffitt Cancer Center |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Kamran A. Ahmed |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida |
| authorships[1].author.id | https://openalex.org/A5091750059 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5923-0677 |
| authorships[1].author.display_name | Priya Kumthekar |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I111979921 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Neuro-Oncology, Northwestern University, Chicago, Illinois |
| authorships[1].institutions[0].id | https://openalex.org/I111979921 |
| authorships[1].institutions[0].ror | https://ror.org/000e0be47 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I111979921 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Northwestern University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Priya U. Kumthekar |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Neuro-Oncology, Northwestern University, Chicago, Illinois |
| authorships[2].author.id | https://openalex.org/A5083755656 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1383-5704 |
| authorships[2].author.display_name | Yolanda Piña |
| authorships[2].countries | US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I3019308854 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, Florida |
| authorships[2].institutions[0].id | https://openalex.org/I3019308854 |
| authorships[2].institutions[0].ror | https://ror.org/01xf75524 |
| authorships[2].institutions[0].type | healthcare |
| authorships[2].institutions[0].lineage | https://openalex.org/I3019308854 |
| authorships[2].institutions[0].country_code | US |
| authorships[2].institutions[0].display_name | Moffitt Cancer Center |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Yolanda Pina |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, Florida |
| authorships[3].author.id | https://openalex.org/A5101832672 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-2307-0330 |
| authorships[3].author.display_name | Youngchul Kim |
| authorships[3].countries | US |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I3019308854 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida |
| authorships[3].institutions[0].id | https://openalex.org/I3019308854 |
| authorships[3].institutions[0].ror | https://ror.org/01xf75524 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I3019308854 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Moffitt Cancer Center |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Youngchul Kim |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Biostatistics, Moffitt Cancer Center, Tampa, Florida |
| authorships[4].author.id | https://openalex.org/A5110558089 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Michael A. Vogelbaum |
| authorships[4].countries | US |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I3019308854 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, Florida |
| authorships[4].institutions[0].id | https://openalex.org/I3019308854 |
| authorships[4].institutions[0].ror | https://ror.org/01xf75524 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I3019308854 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Moffitt Cancer Center |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Michael A. Vogelbaum |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, Florida |
| authorships[5].author.id | https://openalex.org/A5059240684 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0072-0257 |
| authorships[5].author.display_name | Hyo S. Han |
| authorships[5].countries | US |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I3019308854 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida |
| authorships[5].institutions[0].id | https://openalex.org/I3019308854 |
| authorships[5].institutions[0].ror | https://ror.org/01xf75524 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I3019308854 |
| authorships[5].institutions[0].country_code | US |
| authorships[5].institutions[0].display_name | Moffitt Cancer Center |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Hyo S. Han |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Breast Oncology, Moffitt Cancer Center, Tampa, Florida |
| authorships[6].author.id | https://openalex.org/A5088103390 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-3756-8594 |
| authorships[6].author.display_name | Peter Forsyth |
| authorships[6].countries | US |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I3019308854 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, Florida |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I3019308854 |
| authorships[6].affiliations[1].raw_affiliation_string | Department of Tumor Biology, Moffitt Cancer Center, Tampa, Florida |
| authorships[6].institutions[0].id | https://openalex.org/I3019308854 |
| authorships[6].institutions[0].ror | https://ror.org/01xf75524 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I3019308854 |
| authorships[6].institutions[0].country_code | US |
| authorships[6].institutions[0].display_name | Moffitt Cancer Center |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Peter A. Forsyth |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, Florida, Department of Tumor Biology, Moffitt Cancer Center, Tampa, Florida |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11117144 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2024-05-24T00:00:00 |
| display_name | Radiation Therapy Followed by Intrathecal Trastuzumab-Pertuzumab for ERBB2-Positive Breast Leptomeningeal Disease |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11600 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Brain Metastases and Treatment |
| related_works | https://openalex.org/W3139229505, https://openalex.org/W3001641205, https://openalex.org/W2330582602, https://openalex.org/W2769397950, https://openalex.org/W4361939549, https://openalex.org/W2891579961, https://openalex.org/W3165774504, https://openalex.org/W2921099093, https://openalex.org/W2901986589, https://openalex.org/W2019769353 |
| cited_by_count | 7 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 5 |
| counts_by_year[1].year | 2024 |
| counts_by_year[1].cited_by_count | 2 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:11117144 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | JAMA Oncol |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11117144 |
| primary_location.id | doi:10.1001/jamaoncol.2024.1299 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S2756165422 |
| primary_location.source.issn | 2374-2437, 2374-2445 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2374-2437 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | JAMA Oncology |
| primary_location.source.host_organization | https://openalex.org/P4310320259 |
| primary_location.source.host_organization_name | American Medical Association |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320259 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | JAMA Oncology |
| primary_location.landing_page_url | https://doi.org/10.1001/jamaoncol.2024.1299 |
| publication_date | 2024-05-23 |
| publication_year | 2024 |
| referenced_works | https://openalex.org/W2796338303, https://openalex.org/W4292606951, https://openalex.org/W3012380787, https://openalex.org/W4214918751, https://openalex.org/W2619747939, https://openalex.org/W2056330381 |
| referenced_works_count | 6 |
| abstract_inverted_index.by | 12 |
| abstract_inverted_index.of | 7 |
| abstract_inverted_index.and | 15 |
| abstract_inverted_index.for | 17 |
| abstract_inverted_index.the | 5 |
| abstract_inverted_index.(RT) | 10 |
| abstract_inverted_index.This | 0 |
| abstract_inverted_index.with | 19 |
| abstract_inverted_index.trial | 3 |
| abstract_inverted_index.(LMD). | 24 |
| abstract_inverted_index.breast | 21 |
| abstract_inverted_index.safety | 6 |
| abstract_inverted_index.disease | 23 |
| abstract_inverted_index.therapy | 9 |
| abstract_inverted_index.examines | 4 |
| abstract_inverted_index.followed | 11 |
| abstract_inverted_index.patients | 18 |
| abstract_inverted_index.radiation | 8 |
| abstract_inverted_index.controlled | 2 |
| abstract_inverted_index.pertuzumab | 16 |
| abstract_inverted_index.intrathecal | 13 |
| abstract_inverted_index.trastuzumab | 14 |
| abstract_inverted_index.nonrandomized | 1 |
| abstract_inverted_index.ERBB2-positive | 20 |
| abstract_inverted_index.leptomeningeal | 22 |
| cited_by_percentile_year.max | 99 |
| cited_by_percentile_year.min | 94 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.8199999928474426 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.94253017 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |